The 4 most recent market catalysts affecting $QDEL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 85
QuidelOrtho shares are trading lower after the company reported Q2 financial results and cut its FY26 guidance below estimates.
This headline signals a significant negative corporate catalyst for QuidelOrtho. The combination of a Q2 earnings miss and a reduced long-term guidance (FY26) suggests fundamental …
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 85
QuidelOrtho shares are trading lower after the company reported Q2 financial results and cut its FY26 guidance below estimates.
This headline represents a significant corporate catalyst for QuidelOrtho (QDEL). The combination of weaker-than-expected Q2 financial results and a lowered long-term guidance (FY2…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 95
QuidelOrtho Lowers FY2026 Adj EPS Guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 Est; Lowers FY2026 Sales Guidance from $2.700B-$2.750B to $2.520B-$2.600B vs $2.705B Est
QuidelOrtho has issued a stark warning to investors by drastically cutting its fiscal year 2026 adjusted EPS guidance from $1.80-$2.00 to $0.65-$0.90, and sales guidance from $2.70…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 92
QuidelOrtho Q2 Adj. EPS $0.13 Beats $(0.05) Estimate, Sales $631.000M Beat $618.849M Estimate
QuidelOrtho announced Q2 adjusted EPS of $0.13, significantly surpassing the analyst consensus of $(0.05), and sales of $631 million, also beating the $618.849 million estimate. Th…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.